Literature DB >> 26939849

Consequences of bile salt biotransformations by intestinal bacteria.

Jason M Ridlon1, Spencer C Harris2, Shiva Bhowmik3, Dae-Joong Kang2, Phillip B Hylemon2.   

Abstract

Emerging evidence strongly suggest that the human "microbiome" plays an important role in both health and disease. Bile acids function both as detergents molecules promoting nutrient absorption in the intestines and as hormones regulating nutrient metabolism. Bile acids regulate metabolism via activation of specific nuclear receptors (NR) and G-protein coupled receptors (GPCRs). The circulating bile acid pool composition consists of primary bile acids produced from cholesterol in the liver, and secondary bile acids formed by specific gut bacteria. The various biotransformation of bile acids carried out by gut bacteria appear to regulate the structure of the gut microbiome and host physiology. Increased levels of secondary bile acids are associated with specific diseases of the GI system. Elucidating methods to control the gut microbiome and bile acid pool composition in humans may lead to a reduction in some of the major diseases of the liver, gall bladder and colon.

Entities:  

Keywords:  bile acid 7α-dehydroxylation; bile acid oxidoreductases; bile salt hydrolase; gut microbiota; secondary bile acids

Mesh:

Substances:

Year:  2016        PMID: 26939849      PMCID: PMC4856454          DOI: 10.1080/19490976.2015.1127483

Source DB:  PubMed          Journal:  Gut Microbes        ISSN: 1949-0976


  124 in total

1.  Bile acid is a host factor that regulates the composition of the cecal microbiota in rats.

Authors:  K B M Saiful Islam; Satoru Fukiya; Masahito Hagio; Nobuyuki Fujii; Satoshi Ishizuka; Tadasuke Ooka; Yoshitoshi Ogura; Tetsuya Hayashi; Atsushi Yokota
Journal:  Gastroenterology       Date:  2011-08-10       Impact factor: 22.682

2.  Phase III trial of ursodeoxycholic acid to prevent colorectal adenoma recurrence.

Authors:  David S Alberts; María Elena Martínez; Lisa M Hess; Janine G Einspahr; Sylvan B Green; A K Bhattacharyya; Jose Guillen; Mary Krutzsch; Ashok K Batta; Gerald Salen; Liane Fales; Kris Koonce; Dianne Parish; Mary Clouser; Denise Roe; Peter Lance
Journal:  J Natl Cancer Inst       Date:  2005-06-01       Impact factor: 13.506

3.  Requirements for induction of DNA strand breaks by lithocholic acid.

Authors:  M S Kulkarni; B A Cox; K L Yielding
Journal:  Cancer Res       Date:  1982-07       Impact factor: 12.701

4.  Chemoprevention of colorectal cancer with ursodeoxycholic acid: cons.

Authors:  Elizabeth J Carey; Keith D Lindor
Journal:  Clin Res Hepatol Gastroenterol       Date:  2012-09       Impact factor: 2.947

5.  Cell differentiation is a key determinant of cathelicidin LL-37/human cationic antimicrobial protein 18 expression by human colon epithelium.

Authors:  Koji Hase; Lars Eckmann; John D Leopard; Nissi Varki; Martin F Kagnoff
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

6.  LUV's lipid composition modulates diffusion of bile acids.

Authors:  M Hofmann; C Schumann; G Zimmer; K Henzel; U Locher; U Leuschner
Journal:  Chem Phys Lipids       Date:  2001-04       Impact factor: 3.329

7.  High-fat diet determines the composition of the murine gut microbiome independently of obesity.

Authors:  Marie A Hildebrandt; Christian Hoffmann; Scott A Sherrill-Mix; Sue A Keilbaugh; Micah Hamady; Ying-Yu Chen; Rob Knight; Rexford S Ahima; Frederic Bushman; Gary D Wu
Journal:  Gastroenterology       Date:  2009-08-23       Impact factor: 22.682

Review 8.  Cholesterol lowering with bile salt hydrolase-active probiotic bacteria, mechanism of action, clinical evidence, and future direction for heart health applications.

Authors:  Mitchell L Jones; Catherine Tomaro-Duchesneau; Christopher J Martoni; Satya Prakash
Journal:  Expert Opin Biol Ther       Date:  2013-01-28       Impact factor: 4.388

9.  Quantitative estimation of the hydrophilic-hydrophobic balance of mixed bile salt solutions.

Authors:  D M Heuman
Journal:  J Lipid Res       Date:  1989-05       Impact factor: 5.922

10.  Isolation and characterization of thirteen intestinal microorganisms capable of 7 alpha-dehydroxylating bile acids.

Authors:  S Hirano; R Nakama; M Tamaki; N Masuda; H Oda
Journal:  Appl Environ Microbiol       Date:  1981-03       Impact factor: 4.792

View more
  247 in total

1.  Parenteral lipids shape gut bile acid pools and microbiota profiles in the prevention of cholestasis in preterm pigs.

Authors:  Lee Call; Tiffany Molina; Barbara Stoll; Greg Guthrie; Shaji Chacko; Jogchum Plat; Jason Robinson; Sen Lin; Caitlin Vonderohe; Mahmoud Mohammad; Dennis Kunichoff; Stephanie Cruz; Patricio Lau; Muralidhar Premkumar; Jon Nielsen; Zhengfeng Fang; Oluyinka Olutoye; Thomas Thymann; Robert Britton; Per Sangild; Douglas Burrin
Journal:  J Lipid Res       Date:  2020-04-29       Impact factor: 5.922

Review 2.  Thinking Outside the Cereal Box: Noncarbohydrate Routes for Dietary Manipulation of the Gut Microbiota.

Authors:  Aspen T Reese; Rachel N Carmody
Journal:  Appl Environ Microbiol       Date:  2019-05-02       Impact factor: 4.792

3.  Pharmacological Activation of PXR and CAR Downregulates Distinct Bile Acid-Metabolizing Intestinal Bacteria and Alters Bile Acid Homeostasis.

Authors:  Joseph L Dempsey; Dongfang Wang; Gunseli Siginir; Qiang Fei; Daniel Raftery; Haiwei Gu; Julia Yue Cui
Journal:  Toxicol Sci       Date:  2019-03-01       Impact factor: 4.849

Review 4.  Bile acid receptors FXR and TGR5 signaling in fatty liver diseases and therapy.

Authors:  John Y L Chiang; Jessica M Ferrell
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-01-27       Impact factor: 4.052

Review 5.  Bilirubin in the Liver-Gut Signaling Axis.

Authors:  Abdul-Rizaq Hamoud; Lauren Weaver; David E Stec; Terry D Hinds
Journal:  Trends Endocrinol Metab       Date:  2018-02-03       Impact factor: 12.015

Review 6.  Microbial modulation of cardiovascular disease.

Authors:  J Mark Brown; Stanley L Hazen
Journal:  Nat Rev Microbiol       Date:  2018-01-08       Impact factor: 60.633

7.  The 'in vivo lifestyle' of bile acid 7α-dehydroxylating bacteria: comparative genomics, metatranscriptomic, and bile acid metabolomics analysis of a defined microbial community in gnotobiotic mice.

Authors:  Jason M Ridlon; Saravanan Devendran; João Mp Alves; Heidi Doden; Patricia G Wolf; Gabriel V Pereira; Lindsey Ly; Alyssa Volland; Hajime Takei; Hiroshi Nittono; Tsuyoshi Murai; Takao Kurosawa; George E Chlipala; Stefan J Green; Alvaro G Hernandez; Christopher J Fields; Christy L Wright; Genta Kakiyama; Isaac Cann; Purna Kashyap; Vance McCracken; H Rex Gaskins
Journal:  Gut Microbes       Date:  2019-06-09

8.  The Intestinal Microbiome Restricts Alphavirus Infection and Dissemination through a Bile Acid-Type I IFN Signaling Axis.

Authors:  Emma S Winkler; Swathi Shrihari; Barry L Hykes; Scott A Handley; Prabhakar S Andhey; Yan-Jang S Huang; Amanda Swain; Lindsay Droit; Kranthi K Chebrolu; Matthias Mack; Dana L Vanlandingham; Larissa B Thackray; Marina Cella; Marco Colonna; Maxim N Artyomov; Thaddeus S Stappenbeck; Michael S Diamond
Journal:  Cell       Date:  2020-07-14       Impact factor: 41.582

9.  Plasma metabolite abundances are associated with urinary enterolactone excretion in healthy participants on controlled diets.

Authors:  Fayth L Miles; Sandi L Navarro; Yvonne Schwarz; Haiwei Gu; Danijel Djukovic; Timothy W Randolph; Ali Shojaie; Mario Kratz; Meredith A J Hullar; Paul D Lampe; Marian L Neuhouser; Daniel Raftery; Johanna W Lampe
Journal:  Food Funct       Date:  2017-09-20       Impact factor: 5.396

10.  Metabolism of Oxo-Bile Acids and Characterization of Recombinant 12α-Hydroxysteroid Dehydrogenases from Bile Acid 7α-Dehydroxylating Human Gut Bacteria.

Authors:  Heidi Doden; Lina A Sallam; Saravanan Devendran; Lindsey Ly; Greta Doden; Steven L Daniel; João M P Alves; Jason M Ridlon
Journal:  Appl Environ Microbiol       Date:  2018-05-01       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.